Gavin Newsom’s ambitious plan to produce a cheap ... has not started clinical trials or applied for approval from the federal Food and Drug Administration, both of which are likely to take more than a year to complete. During his 2023 State of the ...
Gavin Newsom discussing the emergency response to ... 36 in November 2024, increasing penalties for some theft and drug-related crimes, The Sacramento Bee reported. It raised the penalty for ...
Click to share on X (Opens in new window) Click to share on Facebook (Opens in new window) Click to print (Opens in new window) Click to email a link to a friend (Opens in new window) Gov.
Newsom Committed California to Making Its Own Insulin. It’s at Least a Year Behind His Schedule Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million ...
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced and unlikely to make it to market for ...
The food safety regulatory system is currently managed by multiple federal agencies that each has its own jurisdiction. In response to news of the Boar’s Head outbreak, Nestle stated that “the food safety system … needs an overhaul. Lives are at risk.”
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced
California Gov. Gavin Newsom (D) said he looks forward to President Trump visiting Los Angeles and stands “ready to work” with his administration on issues on which their values align.
Gov. Gavin Newsom faces what may be his greatest political test and leadership challenge. He planned to greet President Trump upon his arrival in Southern California on Friday.
Trump is set to visit California on Friday, and the state’s governor will need to convince the president and congressional Republicans to provide aid to help rebuild Los Angeles.
The Trump administration's "short pause" on communications, expected to end on Feb. 1, has affected FDA updates on food contamination investigations.
The Trump administration’s freeze on communications from U.S. health agencies is leading to another disruption: the abrupt cancellation of scientific meetings. The move covers a swath of health conditions,